Trademark Blog
  • Our Services

Today’s Trademark – InflaRx

  • Older
  • Newer

Today’s Trademark – InflaRx

The trademark of INFLARX is owned by InflaRx GmbH and was registered in USTPO bearing registration number 5682819 on February 26th, 2019.

Today’s Trademark - InflaRx

InflaRx N.V., founded in 2007 in Jena, Germany, is a clinical-stage biopharmaceutical company specializing in the development of monoclonal antibodies targeting the complement system’s C5a protein. Their lead product, vilobelimab, is an anti-C5a monoclonal antibody designed to treat severe inflammatory conditions. Vilobelimab has undergone Phase III clinical trials for hidradenitis suppurativa and is being explored for other conditions, including ANCA-associated vasculitis and pyoderma gangraenosum. Additionally, InflaRx is developing INF904, an oral small molecule aimed at chronic inflammatory and autoimmune diseases. The company is publicly traded on NASDAQ under the ticker IFRX.

  • Categories
    Today's Trademark
  • Author

    Shivangi Gaur

[boomdevs_toc]

Get Monthly

Global IP Updates

Join our community of over 10,000 subscribers and receive monthly updates on the latest IPR news and changes from around the globe.

Leave a Reply Cancel Reply

Your email address will not be published. Required fields are marked *

Related Posts

TODAY’S TRADEMARK – THE ULTIMATE FIGHTING CHAMPIONSHIP

TODAY’S TRADEMARK – SUPERMAN

Trademark of the Week – MARVEL UNIVERSE

Lex Protector

International Law Office

🇺🇸 +1 888 890 6411

Ip Enforcement

Copyright Registration

Subscribe

© Copyright 2012-22. All rights Reserved

Contribute

Recommend

    Subscribe